Co-Authors
This is a "connection" page, showing publications co-authored by Russell Howerton and Perry Shen.
Connection Strength
1.161
-
Chouliaras K, Russell G, Levine E, Howerton R, Votanopoulos K, Clark C, Shen P. Hepatic arterial infusion chemotherapy for colorectal liver metastases revisited. HPB (Oxford). 2020 09; 22(9):1265-1270.
Score: 0.179
-
Moaven O, Clark CJ, Russell GB, Votanopoulos KI, Howerton R, Levine EA, Shen P. Optimal Adjuvant Treatment Approach After Upfront Resection of Pancreatic Cancer: Revisiting the Role of Radiation Based on Pathologic Features. Ann Surg. 2020 Jan 06.
Score: 0.178
-
Enomoto LM, Fenstermaker J, Desnoyers RJ, Pasche BC, Blackstock AW, Howerton RM, Clark CJ, Levine EA, Shen P. Oncology Navigation Decreases Time to Treatment in Patients with Pancreatic Malignancy. Ann Surg Oncol. 2019 May; 26(5):1512-1518.
Score: 0.167
-
Garland M, Addis D, Russell G, Clark C, Levine E, Howerton R, Votanopoulos K, Dobson S, Shen P. The Effect of Regional Anesthesia on Oncologic Outcomes after Resection of Colorectal Hepatic Metastases. Am Surg. 2018 Jan 01; 84(1):29-32.
Score: 0.155
-
Shen P, Blackham AU, Lewis S, Clark CJ, Howerton R, Mogal HD, Dodson RM, Russell GB, Levine EA. Phase II Randomized Trial of Negative-Pressure Wound Therapy to Decrease Surgical Site Infection in Patients Undergoing Laparotomy for Gastrointestinal, Pancreatic, and Peritoneal Surface Malignancies. J Am Coll Surg. 2017 Apr; 224(4):726-737.
Score: 0.145
-
Ihemelandu C, Levine EA, Aklilu M, Yacoub G, Howerton R, Bolemon B, Graham M, Russell G, Shen P. Optimal timing of systemic therapy in resectable colorectal liver metastases. Am Surg. 2013 Apr; 79(4):414-21.
Score: 0.112
-
Shen P, Thai K, Stewart JH, Howerton R, Loggie BW, Russell GB, Levine EA. Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients. Ann Surg Oncol. 2008 Dec; 15(12):3422-32.
Score: 0.081
-
Shen P, Hoffman A, Howerton R, Loggie BW. Cryosurgery of close or positive margins after hepatic resection for primary and metastatic hepatobiliary malignancies. Am Surg. 2002 Aug; 68(8):695-703; discussion 703.
Score: 0.053
-
Cooper WO, Guillamondegui O, Hines OJ, Hultman CS, Kelz RR, Shen P, Spain DA, Sweeney JF, Moore IN, Hopkins J, Horowitz IR, Howerton RM, Meredith JW, Spell NO, Sullivan P, Domenico HJ, Pichert JW, Catron TF, Webb LE, Dmochowski RR, Karrass J, Hickson GB. Use of Unsolicited Patient Observations to Identify Surgeons With Increased Risk for Postoperative Complications. JAMA Surg. 2017 06 01; 152(6):522-529.
Score: 0.037
-
Mogal H, Vermilion SA, Dodson R, Hsu FC, Howerton R, Shen P, Clark CJ. Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy. Ann Surg Oncol. 2017 Jun; 24(6):1714-1721.
Score: 0.036
-
Mishra G, Zhao Y, Sweeney J, Pineau BC, Case D, Ho C, Blackstock AW, Geisinger K, Howerton R, Levine E, Shen P, Ibdah J. Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration. Gastrointest Endosc. 2006 Apr; 63(4):648-54.
Score: 0.017